Fitch Affirms Cigna's Ratings; Outlook Stable
Berkshire's portfolio can give some guidance to weary investors.
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...
UPDATE: The best--and worst--picks from last year's Ira Sohn conference
UPDATE: The best--and worst--investing advice from titans of Wall Street
The best--and worst--picks from last year's Ira Sohn conference
In this second excerpt from their new book, Morningstar's Heather Brilliant and Elizabeth Collins detail how companies leverage cost advantage and switching costs to their benefit.
Health-care exchanges provide the biggest uncertainty going into 2014.
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
Med-tech multinationals look to the East for growth in China.